Share

April 09, 2019; 92 (15 Supplement) May 10, 2019

A Phase 1, Multiple-dose Study of Elezanumab (ABT-555) in Patients with Relapsing Forms of Multiple Sclerosis (S56.001)

Adam Ziemann, Matthew Rosebraugh, Bruce Barger, Bruce Cree
First published April 16, 2019,
Citation
Permissions

Make Comment

See Comments

Downloads
0

Share

Article Information

vol. 92 no. 15 Supplement S56.001
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published April 16, 2019.
Copyright & Usage: 
© 2019

Author Disclosures

    1. Adam Ziemann1,
    2. Matthew Rosebraugh1,
    3. Bruce Barger1 and
    4. Bruce Cree2
  1. Adam Ziemann1,
  2. Matthew Rosebraugh1,
  3. Bruce Barger1 and
  4. Bruce Cree2
  1. 1AbbVie North Chicago IL United States
  2. 2University of California San Francisco, Multiple Sclerosis Center San Francisco CA United States

Article usage

Article usage: April 2019 to April 2023

AbstractFullPdfSource
Apr 20193400Highwire
May 201911100Highwire
Jun 201912200Highwire
Jul 201931700Highwire
Aug 201920400Highwire
Sep 201933600Highwire
Oct 201972900Highwire
Nov 201951800Highwire
Dec 201938200Highwire
Jan 202036500Highwire
Feb 202024800Highwire
Mar 202023100Highwire
Apr 202016800Highwire
May 202021800Highwire
Jun 202020200Highwire
Jul 202023800Highwire
Aug 202021700Highwire
Sep 202024200Highwire
Oct 202024700Highwire
Nov 202013000Highwire
Dec 202011500Highwire
Jan 202110700Highwire
Feb 202112000Highwire
Mar 202114200Highwire
Apr 202110700Highwire
May 20218600Highwire
Jun 20218200Highwire
Jul 20215700Highwire
Aug 20219700Highwire
Sep 20218000Highwire
Oct 20219200Highwire
Nov 20215100Highwire
Dec 20213100Highwire
Jan 20223700Highwire
Feb 20223700Highwire
Mar 20224600Highwire
Apr 20222500Highwire
May 20224800Highwire
Jun 20223200Highwire
Jul 20222400Highwire
Aug 20223100Highwire
Sep 20221400Highwire
Oct 20222000Highwire
Nov 20221900Highwire
Dec 20222300Highwire
Jan 20231700Highwire
Feb 20231600Highwire
Mar 20233400Highwire
Apr 20231700Highwire

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Alert Me